David Owen
Directeur/Membre du Conseil chez Oxford Gene Technology Ltd.
Profil
David Owen is currently a Non-Executive Director at Oxford Gene Technology Ltd., a Director at Diagnostics for the Real World (Europe) Ltd., and a Director at NHS Innovations South East Ltd.
Previously, he served as the Chief Executive Officer of Lifearc from 1990 to 2001.
He also held positions as Chairman at EMBL Enterprise Management Technology Transfer GmbH, Non-Executive Chairman at Abcellute Ltd., and Director at Technology Acquisitions LLC, Compound Photonics Ltd., and Sepal Pharma SA.
Postes actifs de David Owen
| Sociétés | Poste | Début |
|---|---|---|
Oxford Gene Technology Ltd.
 Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | Directeur/Membre du Conseil | 01/10/2005 |
| NHS Innovations South East Ltd. | Directeur/Membre du Conseil | 01/12/2009 |
Diagnostics for the Real World (Europe) Ltd.
 Diagnostics for the Real World (Europe) Ltd. Miscellaneous Commercial ServicesCommercial Services Diagnostics for the Real World (Europe) Ltd. develops diagnostic tests. The firm develops cutting-edge technologies and diagnostic assays for deployment in resource poor countries primarily through patient sample testing at the point of care or near the patient. Its signal amplification technologies offer rapid and reliable tests for Chlamydia, Hepatitis and HIV. The company was founded by Helen Lee in 2002 and is headquartered in Little Chesterford, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de David Owen
| Sociétés | Poste | Fin |
|---|---|---|
Abcellute Ltd.
 Abcellute Ltd. Miscellaneous Commercial ServicesCommercial Services Abcellute was founded in September 2001 as a spinout from the school of biosciences, Cardiff University. Abcellute's core technology is proprietary media Sure Tran -that enables the extended use of fresh cells with out the need for cryopreservation. The company's vision is to achieve global adoption of its SureTran cell transport technology by providing the research community with enhanced, fresh-cell systems. These will maximize the utilization of this often scarce resource and provide products that are much more convenient to use than current fresh-cell systems. This will deliver benefits to biomedical researchers in key areas such as pre-clinical drug evaluation and regenerative medicine. | Président | 20/11/2012 |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | President | 01/01/2001 |
Sepal Pharma SA
 Sepal Pharma SA Pharmaceuticals: MajorHealth Technology Sepal Pharma SA develops cancer therapies. The company was founded on July 20, 2004 and is headquartered in Paris, France. | Directeur/Membre du Conseil | - |
| Technology Acquisitions LLC | Directeur/Membre du Conseil | - |
Compound Photonics Ltd.
 Compound Photonics Ltd. Electronic Production EquipmentElectronic Technology Compound Photonics Ltd. designs and manufactures light modulator products. It offers light engines, laser and radio frequency components. The company was founded by Jerry Woodall and Jonathan A. Sachs in 2008 and is headquartered in Phoenix, AZ. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Oxford Gene Technology Ltd.
Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | Commercial Services |
Abcellute Ltd.
Abcellute Ltd. Miscellaneous Commercial ServicesCommercial Services Abcellute was founded in September 2001 as a spinout from the school of biosciences, Cardiff University. Abcellute's core technology is proprietary media Sure Tran -that enables the extended use of fresh cells with out the need for cryopreservation. The company's vision is to achieve global adoption of its SureTran cell transport technology by providing the research community with enhanced, fresh-cell systems. These will maximize the utilization of this often scarce resource and provide products that are much more convenient to use than current fresh-cell systems. This will deliver benefits to biomedical researchers in key areas such as pre-clinical drug evaluation and regenerative medicine. | Commercial Services |
EMBL Enterprise Management Technology Transfer GmbH
 EMBL Enterprise Management Technology Transfer GmbH Investment ManagersFinance Part of The European Molecular Biology Laboratory, EMBL Enterprise Management Technology Transfer GmbH is an alternative investment manager. The company is based in Heidelberg, Germany. The German company was founded in 1999. The CEO is Gabor M. Lamm. | Finance |
Compound Photonics Ltd.
Compound Photonics Ltd. Electronic Production EquipmentElectronic Technology Compound Photonics Ltd. designs and manufactures light modulator products. It offers light engines, laser and radio frequency components. The company was founded by Jerry Woodall and Jonathan A. Sachs in 2008 and is headquartered in Phoenix, AZ. | Electronic Technology |
| Technology Acquisitions LLC | |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Commercial Services |
Sepal Pharma SA
Sepal Pharma SA Pharmaceuticals: MajorHealth Technology Sepal Pharma SA develops cancer therapies. The company was founded on July 20, 2004 and is headquartered in Paris, France. | Health Technology |
| NHS Innovations South East Ltd. | |
Diagnostics for the Real World (Europe) Ltd.
Diagnostics for the Real World (Europe) Ltd. Miscellaneous Commercial ServicesCommercial Services Diagnostics for the Real World (Europe) Ltd. develops diagnostic tests. The firm develops cutting-edge technologies and diagnostic assays for deployment in resource poor countries primarily through patient sample testing at the point of care or near the patient. Its signal amplification technologies offer rapid and reliable tests for Chlamydia, Hepatitis and HIV. The company was founded by Helen Lee in 2002 and is headquartered in Little Chesterford, the United Kingdom. | Commercial Services |
